81
Participants
Start Date
May 6, 2022
Primary Completion Date
October 24, 2024
Study Completion Date
May 28, 2025
Retriever Thrombectomy
The SolitaireTM X revascularisation device is a self-expanding stent designed for dynamic clot integration with radiopaque markers that enhance visualisation of the optimal working length. After a thrombotic occlusion has been identified and crossed with a guidewire, the stent-retriever thrombectomy proceeds. A microcatheter (e.g., PhenomTM, MarksmanTM) is advanced over the guidewire and once it has traversed the thrombotic occlusion, the SolitaireTM X device is advanced through the microcatheter until the usable length of the stent extends past each side of the thrombus in the vessel. As the microcatheter is retracted to the proximal radiopaque marker of the stent, the stent self-expands and entangles the thrombus. The microcatheter and SolitaireTM X Revascularisation Device are withdrawn as a unit into the guide catheter under continuous aspiration. PCI then proceeds driven by clinical decision making and department guidelines.
Percutaneous Coronary Intervention
Standard of care
Thrombus Aspiration
Standard of care treatment with manual thrombectomy catheter
Oxford Heart Centre, Oxford
Collaborators (1)
Medtronic
INDUSTRY
Terumo Corporation
INDUSTRY
Oxford University Hospitals NHS Trust
OTHER